The study ‘Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer’ was published this month, and begins: “One-fifth of cancers in the United Kingdom are attributable to tobacco smoke, of which cancers of the lung, bladder, and upper aerodigestive tract (combined organs and tissues of the respiratory tract and upper part of the digestive tract, including the lips, mouth, tongue, nose, throat, vocal cords, and part of the esophagus and windpipe) are most common.”
The research team noted that it is estimated between 35% and 62% of patients continue to smoke during the year after they have been diagnosed with cancer. Despite the data indicating that patients can extend their lives by quitting, GPs appear to be reluctant to give them support.
In 2004, the government introduced a pay-for-performance scheme whereby GPs were rewarded if they offered smoking cessation support to patients with one of several smoking-related conditions, but this does not include smoking-related cancers.
The press release accompanying the study states: “While just over a third of lung cancer patients were smoking at diagnosis, those who stopped smoking and survived their treatment lived on average for 1.97 years, compared with 1.08 years for those who did not quit smoking after diagnosis.”
Dr Amanda Farley, lead author and lecturer at the University of Birmingham said: “This research indicates that it is never too late to quit smoking. Although many people think that the damage is done, our research shows that even after a diagnosis of lung cancer, people can still benefit from quitting.”
Professor Paul Aveyard, an Oxfordshire-based GP and Professor of Behavioural Medicine in Oxford University’s Nuffield Department of Primary Care Health Sciences, said: “Our data from these two studies show that cancer patients receive less support to quit smoking from their GP than patients with coronary heart disease, and while absolute quit rates have improved over time they remain lower than they should be. While most lung cancer patients who smoke at diagnosis continue to smoke, those who quit in the first year after diagnosis are likely to live for longer and more comfortably after surviving their cancer treatment than those who continue to smoke.”
“Given this finding, cancer patients who smoke would clearly benefit if GPs became more actively involved in offering support to quit smoking as they do with other smoking-related illnesses. To make this a reality for people with cancer, we need research to understand and support GPs to provide the best support possible for patients with cancer to quit smoking.”
Smoking cessation programs cost GP consortiums money, but convincing patients to try vaping and forging partnerships with local vape shops would cost them very little. Vaping has been shown to work for those most unable to quit smoking, it could well be the ideal solution in this instance.
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous start-ups to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10